WATERTOWN, Mass., Dec. 17, 2025 (GLOBE NEWSWIRE) -- . (“Acrivon” or “Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage ...

Patients in the ratutrelvir arm received ratutrelvir 600 mg orally once daily for 10 days, while patients in the comparator ...

Exploration of key clinical trial data and real-world evidence on dupilumab in asthma and COPD presented at the ERS and CHEST ...

Acrivon Therapeutics (ACRV) will be providing ACR-368 and ACR-2316 clinical data and other updates in January 2026. Topics will include: Updated ...

Comparative trials are among the hardest studies to execute in medtech, especially when the control arm is a long-established ...

Clinical data exchanges are attracting multi billion dollar transactions with high multiples for PE firms including Astorg, ...

Trinity Health Chief Health Informatics Officer Murielle Beene shares how health informaticists are approaching artificial ...

California clinical trial artificial intelligence startup Saama Technologies has teamed up with Big Pharma Pfizer. Under the pact, financials of which have not been disclosed, Pfizer will tap Saama’s ...

A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...

Acrivon Therapeutics, Inc. ('Acrivon” or 'Acrivon Therapeutics”) (Nasdaq: ACRV), a clinical stage biotechnology company ...